Log in

Relevant bibliographies by topics / Carbamazepine / Journal articles

To see the other types of publications on this topic, follow the link: Carbamazepine.

Journal articles on the topic 'Carbamazepine'

Author: Grafiati

Published: 4 June 2021

Last updated: 21 February 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Carbamazepine.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Eimer, Michelle, and Barry L. Carter. "Elevated Serum Carbamazepine Concentrations following Diltiazem Initiation." Drug Intelligence & Clinical Pharmacy 21, no. 4 (April 1987): 340–42. http://dx.doi.org/10.1177/106002808702100408.

Full text

Abstract:

A case of carbamazepine neurotoxicity following the addition of diltiazem is reported. A patient with previously stable carbamazepine serum concentrations was treated with diltiazem for atrial fibrillation and a rapid ventricular response. After three days on the combined regimen, the patient developed neurological symptoms resulting in hospitalization. After a review of the patient's medication usage and carbamazepine concentrations, an interaction between diltiazem and carbamazepine was suspected. Carbamazepine's elimination appears to have been decreased, resulting in neurotoxicity. The toxicity resolved when the carbamazepine dosage was decreased 62 percent.

APA, Harvard, Vancouver, ISO, and other styles

2

Citrome, Leslie. "Use of Lithium, Carbamazepine, and Valproic Acid in a State-Operated Psychiatric Hospital." Journal of Pharmacy Technology 11, no. 2 (March 1995): 55–59. http://dx.doi.org/10.1177/875512259501100210.

Full text

Abstract:

Objective: To examine the prescribing of mood stabilizers (lithium, carbamazepine, and valproic acid) in a 500-bed state-operated psychiatric hospital in New York. Method: All 129 inpatients receiving mood stabilizers were identified and their medical records reviewed using a standardized drug use evaluation form. Diagnosis, other indications, and prior experience with mood stabilizers were examined, as well as outcome and adverse effects. Results: Approximately one-quarter of the inpatient population received a mood stabilizer. The frequency of carbamazepine use exceeded the use of lithium, with 72 patients receiving carbamazepine and only 62 receiving lithium. Twenty-eight patients received valproic acid. Indications found most frequently for carbamazepine use included assaultive or aggressive behavior (70% for those receiving carbamazepine as the only mood stabilizer). Of those patients with bipolar or schizoaffective disorder and receiving either lithium, carbamazepine, or valproic acid, 36% were prescribed carbamazepine (10% as a first-line agent) and 50% lithium (26% as a first-line agent). None of these indications for carbamazepine has been approved by the Food and Drug Administration. In general, positive outcomes were documented but without supporting objective measures. Significant adverse effects were documented in the medical record in one-quarter of the patients. Conclusions: There was widespread use of the three mood stabilizers examined, singly and in combination, for a variety of indications. Lithium and valproic acid remain more frequently prescribed for the treatment of bipolar and schizoaffective disorders. Monotherapy with carbamazepine or valproic acid results in statistically significantly fewer adverse effects than lithium or combination therapy (p values between p = 0.00038 and p = 0.006). Current clinical practice has endorsed the use of carbamazepine for aggressive or assaultive behavior, although there does not appear to be sufficient proof of effectiveness in the literature. Formal studies of carbamazepine's antiagressive effects should be conducted.

APA, Harvard, Vancouver, ISO, and other styles

3

Sonbol, Heba, Hager Ebrahim, Monika Malak, Ahmed Ali, Yasmine Aboulella, Ghada Hadad, Samy Emara, and Ahmed Shawky. "Application of a Small Protein-Coated Column to Trap, Extract and Enrich Carbamazepine Directly from Human Serum for Direct Chromatographic Analysis." Separations 10, no. 2 (January 18, 2023): 71. http://dx.doi.org/10.3390/separations10020071.

Full text

Abstract:

An automated solid phase extraction (SPE) protocol to determine carbamazepine in human serum has been developed and validated using a simple, rabid and sensitive liquid chromatography-based bio-analytical method. Extraction of carbamazepine was carried out using an on-line SPE tool of a short protein-coated (PC) ODS silica pre-column (PC-ODS-pre-column) and phosphate buffer saline (PBS) with a pH of 7.4 as an extraction solvent. There are two distinct chromatographic modes used by PC-ODS-pre-column. While carbamazepine trapping required reversed-phase liquid chromatography, proteins were extracted from serum samples using PBS by size-exclusion liquid chromatography. Then, carbamazepine was eluted from the PC-ODS-pre-column onto the quantification position using a mixture of methanol-distilled deionized water (50:50, v/v) as an eluent and ODS analytical column. At room temperature (22 ± 1 °C), carbamazepine was completely separated from the co-eluted matrix components and detected at 230 nm. Carbamazepine’s linearity was obtained at concentrations ranging from 50 to 10,000 ng/mL. With good accuracy and precision, carbamazepine recoveries in serum samples ranged from 86.14 to 97.82%. The extraction step was conducted using PBS as a safe and green extraction solvent, making this protocol both cost-effective and ecologically safe.

APA, Harvard, Vancouver, ISO, and other styles

4

Damor, Rahul R., Amita R. Kubavat, and Kiran G. Piparva. "Drug reaction with eosinophilia and systemic symptom induced by carbamazepine: a case report." International Journal of Basic & Clinical Pharmacology 8, no. 5 (April 23, 2019): 1115. http://dx.doi.org/10.18203/2319-2003.ijbcp20191610.

Full text

Abstract:

Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a severe, potentially life-threatening acute adverse drug reaction (ADR), typically characterized by a long latency period (2-6 weeks to 3 months) from drug exposure. DRESS syndrome is defined by the presence of fever, cutaneous eruption, lymphadenopathy, systemic or asymptomatic internal organ involvement (e.g. Hepatitis, carditis, interstitial nephritis, interstitial pneumonitis, etc.) and haematological abnormalities, mainly leucocytosis, eosinophilia and sometimes atypical lymphocytosis. There are around 50 culprit drugs which cause DRESS syndrome e.g. carbamazepine, phenytoin, allopurinol, sulfa derivatives, antidepressants, antiepileptics, non-steroidal anti-inflammatory drugs and antimicrobials. The incidence of DRESS syndrome has been estimated to be between 1 in 1,000 and 1 in 10,000 drug exposures. There are many reported cases of DRESS syndrome due to carbamazepine, phenytoin, vancomycin, levitiracitam, ceftriaxone etc. Author presented a case of DRESS syndrome by carbamazepin. RegiSCAR and Japanese consensus group have developed specific criteria for making the diagnosis of DRESS syndrome. The patient described here met the majority of criteria according to RegiSCAR scoring guidelines for a diagnosis of DRESS syndrome induced by carbamazepine. As per RegiSCAR diagnostic criteria author had concluded that this was a “Definite” case of DRESS (Drug Reaction with Eosinophilia and Systemic Symptom) syndrome induced by carbamazepine. Carbamazepine is most common broad-spectrum antiepileptic drugs so, this case report will raises awareness among physician to suspect DRESS syndrome in patients who present unusual complaints and skin findings after starting antiepileptic drugs.

APA, Harvard, Vancouver, ISO, and other styles

5

&NA;. "Carbamazepine see Lithium/carbamazepine." Reactions Weekly &NA;, no. 303 (June 1990): 4. http://dx.doi.org/10.2165/00128415-199003030-00007.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

&NA;. "Carbamazepine." Reactions Weekly &NA;, no. 1384 (January 2012): 16. http://dx.doi.org/10.2165/00128415-201213840-00058.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

&NA;. "Carbamazepine." Reactions Weekly &NA;, no. 1386 (January 2012): 14. http://dx.doi.org/10.2165/00128415-201213860-00047.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

&NA;. "Carbamazepine." Reactions Weekly &NA;, no. 1389 (February 2012): 15. http://dx.doi.org/10.2165/00128415-201213890-00046.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

&NA;. "Carbamazepine." Reactions Weekly &NA;, no. 1391 (March 2012): 15. http://dx.doi.org/10.2165/00128415-201213910-00052.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

&NA;. "Carbamazepine." Reactions Weekly &NA;, no. 1392 (March 2012): 15. http://dx.doi.org/10.2165/00128415-201213920-00041.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

&NA;. "Carbamazepine." Reactions Weekly &NA;, no. 1393 (March 2012): 12–13. http://dx.doi.org/10.2165/00128415-201213930-00034.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

&NA;. "Carbamazepine." Reactions Weekly &NA;, no. 1393 (March 2012): 13. http://dx.doi.org/10.2165/00128415-201213930-00038.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

&NA;. "Carbamazepine." Reactions Weekly &NA;, no. 1393 (March 2012): 13. http://dx.doi.org/10.2165/00128415-201213930-00039.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

&NA;. "Carbamazepine." Reactions Weekly &NA;, no. 1393 (March 2012): 13. http://dx.doi.org/10.2165/00128415-201213930-00040.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

&NA;. "Carbamazepine." Reactions Weekly &NA;, no. 1394 (March 2012): 13. http://dx.doi.org/10.2165/00128415-201213940-00040.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

&NA;. "Carbamazepine." Reactions Weekly &NA;, no. 1394 (March 2012): 13–14. http://dx.doi.org/10.2165/00128415-201213940-00041.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

&NA;. "Carbamazepine." Reactions Weekly &NA;, no. 1395 (March 2012): 12–13. http://dx.doi.org/10.2165/00128415-201213950-00038.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

&NA;. "Carbamazepine." Reactions Weekly &NA;, no. 696 (April 1998): 6. http://dx.doi.org/10.2165/00128415-199806960-00016.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

&NA;. "Carbamazepine." Reactions Weekly &NA;, no. 701 (May 1998): 6. http://dx.doi.org/10.2165/00128415-199807010-00014.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

&NA;. "Carbamazepine." Reactions Weekly &NA;, no. 705 (June 1998): 6. http://dx.doi.org/10.2165/00128415-199807050-00019.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

&NA;. "Carbamazepine." Reactions Weekly &NA;, no. 707 (June 1998): 8. http://dx.doi.org/10.2165/00128415-199807070-00024.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

&NA;. "Carbamazepine." Reactions Weekly &NA;, no. 714 (August 1998): 6–7. http://dx.doi.org/10.2165/00128415-199807140-00017.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

&NA;. "Carbamazepine." Reactions Weekly &NA;, no. 726 (November 1998): 6–7. http://dx.doi.org/10.2165/00128415-199807260-00014.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

&NA;. "Carbamazepine." Reactions Weekly &NA;, no. 728 (November 1998): 6. http://dx.doi.org/10.2165/00128415-199807280-00016.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

&NA;. "Carbamazepine." Reactions Weekly &NA;, no. 746 (April 1999): 6. http://dx.doi.org/10.2165/00128415-199907460-00014.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

&NA;. "Carbamazepine." Reactions Weekly &NA;, no. 746 (April 1999): 6–7. http://dx.doi.org/10.2165/00128415-199907460-00015.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

&NA;. "Carbamazepine." Reactions Weekly &NA;, no. 759 (July 1999): 5–6. http://dx.doi.org/10.2165/00128415-199907590-00009.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

&NA;. "Carbamazepine." Reactions Weekly &NA;, no. 1166 (August 2007): 7. http://dx.doi.org/10.2165/00128415-200711660-00020.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

&NA;. "Carbamazepine." Reactions Weekly &NA;, no. 1167 (September 2007): 9. http://dx.doi.org/10.2165/00128415-200711670-00027.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

&NA;. "Carbamazepine." Reactions Weekly &NA;, no. 1168 (September 2007): 9–10. http://dx.doi.org/10.2165/00128415-200711680-00025.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

&NA;. "Carbamazepine." Reactions Weekly &NA;, no. 1171 (September 2007): 9. http://dx.doi.org/10.2165/00128415-200711710-00021.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

&NA;. "Carbamazepine." Reactions Weekly &NA;, no. 1174 (October 2007): 9. http://dx.doi.org/10.2165/00128415-200711740-00025.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

&NA;. "Carbamazepine." Reactions Weekly &NA;, no. 1177 (November 2007): 8–9. http://dx.doi.org/10.2165/00128415-200711770-00019.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

&NA;. "Carbamazepine." Reactions Weekly &NA;, no. 1177 (November 2007): 9. http://dx.doi.org/10.2165/00128415-200711770-00021.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

&NA;. "Carbamazepine." Reactions Weekly &NA;, no. 1180 (December 2007): 9. http://dx.doi.org/10.2165/00128415-200711800-00025.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

&NA;. "Carbamazepine." Reactions Weekly &NA;, no. 1183 (January 2008): 9–10. http://dx.doi.org/10.2165/00128415-200811830-00024.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

&NA;. "Carbamazepine." Reactions Weekly &NA;, no. 1189 (February 2008): 11. http://dx.doi.org/10.2165/00128415-200811890-00032.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

&NA;. "Carbamazepine." Reactions Weekly &NA;, no. 1191 (March 2008): 7. http://dx.doi.org/10.2165/00128415-200811910-00017.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

&NA;. "Carbamazepine." Reactions Weekly &NA;, no. 1194-1195 (March 2008): 11. http://dx.doi.org/10.2165/00128415-200811940-00034.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

&NA;. "Carbamazepine." Reactions Weekly &NA;, no. 1122 (October 2006): 7. http://dx.doi.org/10.2165/00128415-200611220-00019.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

&NA;. "Carbamazepine." Reactions Weekly &NA;, no. 1123 (October 2006): 7. http://dx.doi.org/10.2165/00128415-200611230-00020.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

&NA;. "Carbamazepine." Reactions Weekly &NA;, no. 1124 (October 2006): 8–9. http://dx.doi.org/10.2165/00128415-200611240-00024.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

&NA;. "Carbamazepine." Reactions Weekly &NA;, no. 1135 (January 2007): 12. http://dx.doi.org/10.2165/00128415-200711350-00044.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

&NA;. "Carbamazepine." Reactions Weekly &NA;, no. 1148 (April 2007): 12. http://dx.doi.org/10.2165/00128415-200711480-00038.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

&NA;. "Carbamazepine." Reactions Weekly &NA;, no. 1149 (April 2007): 9–10. http://dx.doi.org/10.2165/00128415-200711490-00025.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

&NA;. "Carbamazepine." Reactions Weekly &NA;, no. 1149 (April 2007): 10. http://dx.doi.org/10.2165/00128415-200711490-00028.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

&NA;. "Carbamazepine." Reactions Weekly &NA;, no. 1153 (May 2007): 8. http://dx.doi.org/10.2165/00128415-200711530-00026.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

&NA;. "Carbamazepine." Reactions Weekly &NA;, no. 1156 (June 2007): 9. http://dx.doi.org/10.2165/00128415-200711560-00029.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

&NA;. "Carbamazepine." Reactions Weekly &NA;, no. 1354 (June 2011): 14. http://dx.doi.org/10.2165/00128415-201113540-00045.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

&NA;. "Carbamazepine." Reactions Weekly &NA;, no. 1355 (June 2011): 12. http://dx.doi.org/10.2165/00128415-201113550-00036.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!